gvtcx

Revalidation Evaluation Partner

GENERAL PHARMACEUTICAL COUNCIL Published 17 Apr 2024 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£39,550
Statuscomplete
Category (CPV) 73000000
Deadline29 Feb 2024
Contract start8 Apr 2024
Contract end31 Mar 2025
Procedureselective
SME suitableYes
OCIDocds-b5fd17-ebacb15e-d30a-4cd6-8f84-0ff01d68b84c

Award

SupplierValueDateStatus
Grant Thornton UK LLP £39,550 31 Mar 2024 active

description

The aim of this project is to undertake a review of our revalidation process, engaging with internal and stakeholders and analysing revalidation data. The evaluation should consider the revalidation process from the perspective of the registrant (both pharmacists and pharmacy technicians), other stakeholders and from the GPhC perspective. The focus should be on the current set- up and consideration for future changes, but not on previous iterations.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Apr 2024 Award (award) · 3745e3b4-c862-4d06-81bf-cd3e436ba41c-741866

more from GENERAL PHARMACEUTICAL COUNCIL

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.